Showing results (131-140 of 214) with videos related to
Sort By:
Pageof 22
Cancer Research|October 15, 1991
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical studyA L Jackman, G A Taylor, W Gibson, et al.Cancer Treatment Reports|January 1, 1981
Methotrexate with thymidine, inosine, and allopurinol rescue: a phase I clinical studyP J Dady, G A Taylor, J F Muindi, et al.British Journal of Cancer|December 1, 1987
Tumour necrosis factor in man: clinical and biological observationsP Selby, S Hobbs, C Viner, et al.Oncology|January 1, 1978
Improved results in combination chemotherapy of head and neck cancer using a kinetically-based approach: a randomised study with and without adriamycinL A Price, B T Hill, A H Calvert, et al.Human Pathology|May 23, 2008
Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancerS J Wilkinson, A Kucukmetin, P Cross, et al.Journal of Medicinal Chemistry|April 1, 1986
Quinazoline antifolates inhibiting thymidylate synthase: benzoyl ring modificationsT R Jones, M J Smithers, M A Taylor, et al.Seminars in Oncology|December 1, 1996
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee studyD Porter, A Boddy, H Thomas, et al.European Journal of Cancer & Clinical Oncology|September 1, 1987
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatinD R Newell, Z H Siddik, L A Gumbrell, et al.The Journal of Organic Chemistry|July 7, 2023
Traceless Thioacid-Mediated Radical Cyclization of 1,6-DienesDylan M Lynch, Mark D Nolan, Conor Williams, et al.Seminars in Oncology|October 1, 1995
Carboplatin in combination with paclitaxel in advanced ovarian cancer: dose determination and pharmacokinetic and pharmacodynamic interactionsA H Calvert, A Boddy, N P Bailey, et al.Pageof 22